Risk Factors and Time to Occurrence of Genitourinary Toxicity After External Beam Radiotherapy for Prostate Cancer

被引:0
作者
Kanemoto, Ayae [1 ]
Matsumoto, Yasuo [1 ]
Sugita, Tadashi [1 ]
Abe, Eisuke [3 ]
Yamana, Nobuko [3 ]
Saito, Toshihiro [2 ]
Kobayashi, Kazuhiro [2 ]
Yamazaki, Hiroyuki [2 ]
Bilim, Vladimir [2 ]
Tanikawa, Toshiki [2 ]
机构
[1] Niigata Canc Ctr Hosp, Dept Radiat Oncol, 2-15-3 Kawagishi Cho, Niigata 9518566, Japan
[2] Niigata Canc Ctr Hosp, Dept Urol, 2-15-3 Kawagishi Cho, Niigata 9518566, Japan
[3] Niigata Univ, Med & Dent Hosp, Dept Radiat Oncol, Niigata, Japan
关键词
Genitourinary toxicity; timing; risk factor; external-beam radiotherapy; prostate cancer; CONFORMAL RADIOTHERAPY; HORMONAL-THERAPY; DOSE-ESCALATION; TRIAL; OUTCOMES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To retrospectively investigate the risk factors and time to occurrence of genitourinary (GU) toxicity after radiotherapy for localized prostate cancer. Patients and Methods: The study included 320 patients. The radiotherapy planning target volume encompassed the prostate with a 1-cm margin in the transverse plane and a 1-cm margin (Group A) or a 1.5-cm margin (Group B) in the longitudinal plane. Incidence rates, risk factors and time to occurrence of GU toxicity were evaluated. Results: After a median follow-up of 38.2 months, the rate of late grade 2-3 GU toxicity was 5.9% and the median interval was 18.3 months. The wider longitudinal margin was the single significant independent factor. The 2-year cumulative incidence rates of late grade >= 2 GU toxicity were 2.8% and 7.5% in Group A and B patients. Conclusion: A wider radiotherapy margin increased the risk of GU toxicity and led to earlier occurrence.
引用
收藏
页码:2441 / 2444
页数:4
相关论文
共 50 条
  • [31] Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
    Mathieu, Romain
    Ospina Arango, Juan David
    Beckendorf, Veronique
    Delobel, Jean-Bernard
    Messai, Taha
    Chira, Ciprian
    Bossi, Alberto
    Prise, Elisabeth Le
    Guerif, Stephane
    Simon, Jean-Marc
    Dubray, Bernard
    Zhu, Jian
    Lagrange, Jean-Leon
    Pommier, Pascal
    Gnep, Khemara
    Acosta, Oscar
    De Crevoisier, Renaud
    WORLD JOURNAL OF UROLOGY, 2014, 32 (03) : 743 - 751
  • [32] Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer
    Freiberger, Carla
    Berneking, Vanessa
    Voegeli, Thomas-Alexander
    Kirschner-Hermanns, Ruth
    Eble, Michael J.
    Pinkawa, Michael
    BRACHYTHERAPY, 2018, 17 (03) : 517 - 523
  • [33] Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
    Guo, Yadong
    Mao, Shiyu
    Zhang, Aihong
    Zhang, Junfeng
    Wang, Longsheng
    Wang, Ruiliang
    Zhang, Wentao
    Zhang, Ziwei
    Wu, Yuan
    Cao, Xuan
    Yang, Bin
    Yao, Xudong
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [34] Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients
    Goldner, Gregor
    Poetter, Richard
    Battermann, Jan J.
    Kirisits, Christian
    Schmid, Maximilian P.
    Sljivic, Samir
    van Vulpen, Marco
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) : 223 - 227
  • [35] Class solutions for conformal external beam prostate radiotherapy
    Khoo, VS
    Bedford, JL
    Webb, S
    Dearnaley, DP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (04): : 1109 - 1120
  • [36] Risk factors for rectal bleeding after volumetric-modulated arc radiotherapy of prostate cancer
    Otsuka, Kenichiro
    Otsuka, Makoto
    Itaya, Takayoshi
    Matsumoto, Akira
    Sato, Ryuta
    Sagara, Yoshiko
    Oga, Masatoshi
    Asayama, Yoshiki
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2023, 28 (01) : 15 - 23
  • [37] Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis
    Ashesh B Jani
    Christopher M Hand
    Charles A Pelizzari
    John C Roeske
    Lani Krauz
    Srinivasan Vijayakumar
    BMC Cancer, 3
  • [38] Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
    Yamada, Yasuhiro
    Okihara, Koji
    Iwata, Tsuyoshi
    Masui, Koji
    Kamoi, Kazumi
    Yamada, Kei
    Miki, Tsuneharu
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (06) : 899 - 903
  • [39] Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy
    Stephenson A.J.
    Scardino P.T.
    Bianco Jr. F.J.
    Eastham J.A.
    Current Treatment Options in Oncology, 2004, 5 (5) : 357 - 365
  • [40] Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer
    McDonough, MJ
    Feldmeier, JJ
    Parsai, I
    Dobelbower, RR
    Selman, SH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03): : 624 - 627